# Infosys Ltd: financial statements, quarterly

INFY · NYSE · CIK 1067491 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/infy.md) · [Financials](/companies/infy/financials.md) · [Filings](/companies/infy/filings.md) · [Insiders](/companies/infy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/infy/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-03-31) | period not labelled (2016-03-31) | period not labelled (2017-03-31) | FY2018 (2018-03-31) | FY2019 (2019-03-31) | FY2020 (2020-03-31) | FY2021 (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | [3.5](/filings/0001564590-20-027585.md) | [3.0](/filings/0001564590-21-032573.md) | [2.8](/filings/0001564590-22-023521.md) | [2.5](/filings/0000950170-23-028187.md) | [3.4](/filings/0000950170-24-076649.md) | [2.3](/filings/0000950170-25-091925.md) | [1.5](/filings/0000950170-25-091925.md) | [1.8](/filings/0000950170-25-091925.md) | [2.9](/filings/0000950170-25-091925.md) |
| Current assets | $bn | not reported | not reported | [8.3](/filings/0001564590-18-016985.md) | [7.7](/filings/0001564590-19-022837.md) | [7.6](/filings/0001564590-20-027585.md) | [7.2](/filings/0001564590-21-032573.md) | [8.3](/filings/0001564590-22-023521.md) | [8.9](/filings/0000950170-23-028187.md) | [8.6](/filings/0000950170-24-076649.md) | [10.7](/filings/0000950170-25-091925.md) | [11.4](/filings/0000950170-25-091925.md) |
| Total assets | $bn | not reported | not reported | [12.9](/filings/0001564590-18-016985.md) | [12.3](/filings/0001564590-19-022837.md) | [12.3](/filings/0001564590-20-027585.md) | [12.3](/filings/0001564590-21-032573.md) | [14.8](/filings/0001564590-22-023521.md) | [15.6](/filings/0000950170-23-028187.md) | [15.3](/filings/0000950170-24-076649.md) | [16.5](/filings/0000950170-25-091925.md) | [17.4](/filings/0000950170-25-091925.md) |
| Current liabilities | $bn | not reported | not reported | [2.2](/filings/0001564590-18-016985.md) | [2.2](/filings/0001564590-19-022837.md) | [2.7](/filings/0001564590-20-027585.md) | [2.8](/filings/0001564590-21-032573.md) | [3.3](/filings/0001564590-22-023521.md) | [4.4](/filings/0000950170-23-028187.md) | [4.8](/filings/0000950170-24-076649.md) | [4.7](/filings/0000950170-25-091925.md) | [5.0](/filings/0000950170-25-091925.md) |
| Total liabilities | $bn | not reported | not reported | [2.2](/filings/0001564590-18-016985.md) | [2.3](/filings/0001564590-19-022837.md) | [2.9](/filings/0001564590-20-027585.md) | [3.6](/filings/0001564590-21-032573.md) | [4.3](/filings/0001564590-22-023521.md) | [5.6](/filings/0000950170-23-028187.md) | [6.1](/filings/0000950170-24-076649.md) | [5.9](/filings/0000950170-25-091925.md) | [6.2](/filings/0000950170-25-091925.md) |
| Shareholders' equity | $bn | [8.8](/filings/0001564590-18-016985.md) | [9.3](/filings/0001564590-19-022837.md) | [10.6](/filings/0001564590-18-016985.md) | [10.0](/filings/0001564590-19-022837.md) | [9.4](/filings/0001564590-20-027585.md) | [8.6](/filings/0001564590-21-032573.md) | [10.4](/filings/0001564590-22-023521.md) | [9.9](/filings/0000950170-23-028187.md) | [9.2](/filings/0000950170-24-076649.md) | [10.6](/filings/0000950170-25-091925.md) | [11.2](/filings/0000950170-25-091925.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 4,055,591,723 at 2026-03-31, from the cover of the [20-F filed 2026-06-15](/filings/0001193125-26-270520.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.